Please find below the abstracts and corresponding posters presented at ECOP 7. Please note that only posters that were displayed onsite at ECOP 7 have been published.
APr 009 – Assessment of Occupational Exposure Risk to Cytotoxic Agents in a Hospital Drug Compounding Unit
ClPh 047 – Impact of systematic clinical pharmacist review on oncology patients treatment requiring gastric tube placement
DSt 073 – Surprising news about a well known incompatibility in PCA pumps
QuM 097 – Impact of robotic systems on the preparation of infusion chemotherapy: enhanced safety, traceability, and the evolving role of the Hospital Pharmacist at the National Cancer Institute of Milan
Saturday, 13th June 2026
ClEv 019 – PROGNOSTIC ROLE OF THE PLATELET-LYMPHOCYTE RATIO IN PATIENTS WITH LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER TREATED WITH DURVALUMAB AFTER CHEMORADIOTHERAPY
ClEv 031 – The prevalence and risk factors of Hand Foot Syndrome induced by chemotherapy
DSt 075 – Extended Physicochemical Stability of Trastuzumab Deruxtecan (1 and 4 mg/mL) in 5% Dextrose Polypropylene Infusion Bags Stored at 4°C
QuM 079 – Quality assurance in oncology clinical trials: pharmacist-led monitoring through daily documentation review to support patient safety
TDM 122 – PRECISION MEDICINE: PHARMACOGENETIC PROFILING AND THERAPEUTIC DRUG MONITORING AS AN INTEGRATED APPROACH TO BREAST CANCER TREATMENT
Dr Christophe Bardin, ECOP 7 Scientific Coordinator abstracts
Prof Dr Robert Terkola, ECOP 7 Chair Scientific Committee